Related Experiment Video
Updated: Jun 14, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis
Vera V Grinkevich1, Fedor Nikulenkov, Yao Shi
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177, Stockholm, Sweden.
Abstract:
Targeting "oncogene addiction" is a promising strategy for anticancer therapy. We report a potent inhibition of crucial oncogenes by p53 upon reactivation by small-molecule RITA in vitro and in vivo. RITA-activated p53 unleashes the transcriptional repression of antiapoptotic proteins Mcl-1, Bcl-2, MAP4, and survivin; blocks the Akt pathway on several levels; and downregulates c-Myc, cyclin E, and beta-catenin. p53 ablates c-Myc expression via several mechanisms at the transcriptional and posttranscriptional level. We show that the threshold for p53-mediated transrepression of survival genes is higher than for transactivation of proapoptotic targets. Inhibition of oncogenes by p53 reduces the cell's ability to buffer proapoptotic signals and elicits robust apoptosis. Our study highlights the role of transcriptional repression for p53-mediated tumor suppression.
Insights
Small-molecule RITA reactivates the tumor suppressor p53, inhibiting crucial oncogenes like Mcl-1 and c-Myc. This RITA-activated p53 strategy effectively triggers cancer cell death by blocking survival pathways and promoting apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapy
Background:
- Targeting oncogene addiction is a key anticancer strategy.
- The tumor suppressor p53 plays a critical role in cancer suppression.
Purpose of the Study:
- To investigate the potential of reactivating p53 using small-molecule RITA for cancer therapy.
- To elucidate the mechanisms by which RITA-activated p53 inhibits oncogenes and induces apoptosis.
Main Methods:
- In vitro and in vivo experiments were conducted.
- Analysis of p53-mediated transcriptional repression and activation.
- Assessment of key oncogenic pathways including Akt and c-Myc.
Main Results:
- RITA reactivated p53, leading to potent inhibition of oncogenes Mcl-1, Bcl-2, MAP4, survivin, c-Myc, cyclin E, and beta-catenin.
- RITA-activated p53 blocked the Akt pathway and downregulated c-Myc through multiple mechanisms.
- The study demonstrated that p53-mediated transcriptional repression of survival genes is crucial for inducing apoptosis.
Conclusions:
- Reactivation of p53 by RITA is a promising strategy for anticancer therapy.
- Transcriptional repression by p53 is a vital mechanism for tumor suppression.
- Targeting oncogene addiction via p53 reactivation holds significant therapeutic potential.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle